The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step boomrx #peptides #fda #compoundingpharmacy #clinicalmedicine #patientaccess BoomRX BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with